Connect with us

Hi, what are you looking for?

Tech

3D-printed blood vessels could improve heart bypass outcomes, research suggests

3D-printed blood vessels which closely mimic the properties of human veins could transform the treatment of cardiovascular diseases, scientists have said.

In a two-stage process, a team of researchers led by the University of Edinburgh’s School of Engineering used a rotating spindle integrated into a 3D printer to create tubular grafts made from a water-based gel.

Next, they reinforced the printed graft in a process known as electrospinning, which uses high voltage to draw out thin nanofibers, coating the artificial blood vessel in biodegradable polyester molecules.

The team said the flexible gel-like tubes, which are as strong as natural blood vessels and could be easily integrated into the body, could replace the human and synthetic veins currently used to re-route blood flow in heart bypass operations.

According to the researchers, this could limit the scarring, pain and infection risk associated with the removal of human veins in the 20,000 heart bypass operations performed each year in England alone.

The team said the tubes, which can be made between 1mm and 40mm in diameter, could reduce the failure of small synthetic grafts which can be hard to integrate into the body.

Lead author Dr Faraz Fazal said: “Our hybrid technique opens up new and exciting possibilities for the fabrication of tubular constructs in tissue engineering.”

Principal investigator Dr Norbert Radacsi added: “The results from our research address a long-standing challenge in the field of vascular tissue engineering – to produce a conduit that has similar biomechanical properties to that of human veins.

“With continued support and collaboration, the vision of improved treatment options for patients with cardiovascular disease could become a reality.”

The next stage of the study will involve researching the use of the blood vessels in animals, in collaboration with the university’s Roslin Institute, followed by trials in humans.

The research, published in Advanced Materials Technologies, was carried out in collaboration with Heriot-Watt University.

This post appeared first on sky.com

    You May Also Like

    Stocks

    In this episode of StockCharts TV‘s The MEM Edge, Mary Ellen reviews what’s shaping up in the broader markets after the Fed announced their rate cut...

    Tech

    Consumer rights group Which? is suing Apple for £3bn over the way it deploys the iCloud. If the lawsuit succeeds, around 40 million Apple...

    Tech

    Battle lines have been drawn between the almost 200 countries meeting in Azerbaijan as they seek to agree a new pot of money to...

    Tech

    Meta has lowered the minimum age to use the popular messaging platform WhatsApp. The move, which came into effect on Thursday, reduces the age...

    Disclaimer: globalwashingtonwebinar.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 globalwashingtonwebinar.com | All Rights Reserved